The legacy of the blue pill offers a complex case study for stakeholders eyeing drug companies. While initial sales were astounding, recent patent expiry and the rise of cheaper versions have severely affected https://maeemfx733712.bloggosite.com/48892348/sildenafil-and-pharma-a-risky-stake